Current status:
Cancelled Post Market
Current status date:
2003-07-04
DIN:
02242743
Electronic product monograph is not available
Route(s) of administration:
Oral
Number of active ingredient(s):
4
Anatomical Therapeutic Chemical (ATC):
See footnote 4
A09AA02 MULTIENZYMES (LIPASE, PROTEASE ETC)
List of active ingredient(s)
Active ingredient(s)
See footnote8
|
Strength |
AMYLASE
|
50 MG
|
CELLULASE
|
25 MG
|
LACTASE
|
125 UNIT
|
PAPAIN
|
150 MG
|